Recombination hotspot in NF1 microdeletion patients

Human Molecular Genetics

Volumn 10, Issue 13, 2001, Pages 1387-1392

  López Correa, Catalina ^a   Dorschner, Michael ^b   Brems, Hilde ^a   Lázaro, Conxi ^c   Clementi, Maurizio ^d   Upadhyaya, Meena ^e   Dooijes, Dennis ^f   Moog, Ute ^g   Kehrer Sawatzki, Hildegard ^h   Rutkowski, J Lynn ⁱ   Fryns, Jean Pierre ^a   Marynen, Peter ^a   Stephens, Karen ^b   Legius, Eric ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF WASHINGTON   (United States)

^c HOSPITAL DURAN I REYNALS   (Spain)

^d UNIVERSITY OF PADOVA   (Italy)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h UNIVERSITY OF ULM   (Germany)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; NF1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC PROCEDURE; GENE CONVERSION; GENE DELETION; GENE MAPPING; GENETIC RECOMBINATION; GENETIC SCREENING; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; NEUROFIBROMA; NEUROFIBROMATOSIS; NONHUMAN; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MOTIF; RODENT; SEQUENCE ANALYSIS;

ANIMALIA; RODENTIA;

EID: 0035875064     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.13.1387     Document Type: Article

References (32)

1. Clinical and epidemiological features
2. Neurofibromatosis type 1: A model condition for the study of the molecular basis of variable expressivity in human disorders
3. Neurofibromatosis 1: A clinical and genetic overview
4. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects
5. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
6. Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay
7. Identification of de novo deletions at the NF1 gene: No preferential paternal origin and phenotypic analysis of patients
8. Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1
9. Deletions spanning the neurofibromatosis type 1 gene: Implications for genotype-phenotype correlations in neurofibromatosis type 1?
10. Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism
11. Deletions spanning the neurofibromatosis 1 gene: Identification and phenotype of five patients
12. Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions
13. Deletion of the entire NF1 gene detected by FISH: Four deletion patients associated with severe manifestations
14. The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization
15. Familial neurofibromatosis 1 gene deletions: Cosegregation with distinctive facial features and early onset of cutaneous neurofibromas
16. Do NF1 gene deletions result in a characteristic phenotype?
17. NF1 microdeletion breakpoints are clustered at flanking repetitive sequences
18. Unequal meiotic crossover: A frequent cause of NF1 microdeletions
19. Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients
20. Genomic disorders: Structural features of the genome can lead to DNA rearrangements and human disease traits
21. Overview of hereditary neuropathy with liability to pressure palsies
22. Molecular mechanisms for CMT1A duplication and HNPP deletion
23. Sex-dependent rearrangements resulting in CMT1A and HNPP
24. Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients
25. Primate origin of the CMT1A-REP repeat and analysis of a putative transposon-associated recombinational hotspot
26. Unequal exchange at the Charcot-Marie-tooth disease type 1A recombination hot-spot is not elevated above the genome average rate
27. Methods for rapid detection of a recurrent nonsense mutation and documentation of phenotypic features in neurofibromatosis type 1 patients
28. Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion
29. Somatic mosaicism in a patient with neurofibromatosis type 1
30. Somatic mosaicism for deletion of the entire NF1 gene identified by FISH
31. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
32. Crossover breakpoint mapping identifies a subtelomeric hotspot for male meiotic recombination